Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TXG | Class A Common Stock | Options Exercise | $13.3K | +11.1K | +23.42% | $1.20* | 58.6K | Aug 2, 2021 | Direct | F1 |
transaction | TXG | Class A Common Stock | Options Exercise | $154K | +30.6K | +52.17% | $5.04* | 89.1K | Aug 2, 2021 | Direct | F1 |
transaction | TXG | Class A Common Stock | Sale | -$1.05M | -5.9K | -6.62% | $178.25 | 83.2K | Aug 2, 2021 | Direct | F1, F2 |
transaction | TXG | Class A Common Stock | Sale | -$1.44M | -8.05K | -9.67% | $179.08 | 75.2K | Aug 2, 2021 | Direct | F1, F3 |
transaction | TXG | Class A Common Stock | Sale | -$1.93M | -10.7K | -14.25% | $180.13 | 64.5K | Aug 2, 2021 | Direct | F1, F4 |
transaction | TXG | Class A Common Stock | Sale | -$1.59M | -8.8K | -13.65% | $181.13 | 55.7K | Aug 2, 2021 | Direct | F1, F5 |
transaction | TXG | Class A Common Stock | Sale | -$946K | -5.2K | -9.34% | $181.98 | 50.5K | Aug 2, 2021 | Direct | F1, F6 |
transaction | TXG | Class A Common Stock | Sale | -$329K | -1.8K | -3.57% | $183.02 | 48.7K | Aug 2, 2021 | Direct | F1, F7 |
transaction | TXG | Class A Common Stock | Sale | -$147K | -800 | -1.64% | $184.02 | 47.9K | Aug 2, 2021 | Direct | F1, F8 |
transaction | TXG | Class A Common Stock | Sale | -$74K | -400 | -0.84% | $184.95 | 47.5K | Aug 2, 2021 | Direct | F1, F9 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TXG | Stock Option (right to buy) | Options Exercise | $0 | -11.1K | -15.64% | $0.00 | 60K | Aug 2, 2021 | Class A Common Stock | 11.1K | $1.20 | Direct | F1, F10 |
transaction | TXG | Stock Option (right to buy) | Options Exercise | $0 | -30.6K | -17.46% | $0.00 | 144K | Aug 2, 2021 | Class A Common Stock | 30.6K | $5.04 | Direct | F1, F11 |
Id | Content |
---|---|
F1 | The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. |
F2 | This transaction was executed in multiple trades at prices ranging from $177.63 to $178.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F3 | This transaction was executed in multiple trades at prices ranging from $178.63 to $179.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F4 | This transaction was executed in multiple trades at prices ranging from $179.63 to $180.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F5 | This transaction was executed in multiple trades at prices ranging from $180.63 to $181.625. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F6 | This transaction was executed in multiple trades at prices ranging from $181.63 to $182.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F7 | This transaction was executed in multiple trades at prices ranging from $182.63 to $183.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F8 | This transaction was executed in multiple trades at prices ranging from $183.66 to $184.595. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F9 | This transaction was executed in multiple trades at prices ranging from $184.84 to $184.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F10 | This option, originally for 200,000 shares, of which 140,032 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
F11 | This option, originally for 175,000 shares, of which 30,552 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Chief Scientific Officer and President